Article Information
History
- July 31, 2024.
Article Versions
- Version 1 (May 25, 2023 - 09:30).
- Version 2 (April 3, 2024 - 11:12).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Donghyuk Lee1,2,
- Min Hua1,
- Difei Wang1,
- Lei Song1,
- Tongwu Zhang1,
- Xing Hua1,
- Kai Yu1,
- Xiaohong R. Yang1,
- Stephen J. Chanock1,
- Jianxin Shi1,
- Maria Teresa Landi1 and
- Bin Zhu1,*
- 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- 2Department of Statistics, Pusan National University, Busan, Korea
- ↵*Corresponding author: Bin Zhu (bin.zhu{at}nih.gov)
Posted July 31, 2024.
Pan-cancer mutational signature analysis of 111,711 targeted sequenced tumors using SATS
